National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 3866-3867 [06-657]
Download as PDF
3866
Federal Register / Vol. 71, No. 15 / Tuesday, January 24, 2006 / Notices
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel. EHealth Applications of Empirically
Supported Therapies in English and/or
Spanish.
Date: February 15, 2006.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401. (301)
435–1439. lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Agenda: to review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Annie Walker-Abbey, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institute of Health/
NIAID, 6700B Rockledge Drive, RM. 3266,
Bethesda, MD 20892–7616, (301)–451–2671,
aabbey@niaid.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 11, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–653 Filed 1–23–06; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rmajette on PROD1PC67 with NOTICES1
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussion could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Microbiology and Infectious Diseases
Research Committee.
Date: February 21–23, 2006.
Time: 8 a.m. to 6 p.m.
VerDate Aug<31>2005
14:44 Jan 23, 2006
Jkt 208001
Dated: January 11, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–655 Filed 1–23–06; 8:45 am]
Contact Person: Gary J. Nabel, MD, PhD,
Director, Vaccine Research Center, NIAID/
NIH, 40 Convent Drive, Bldg 40, Room 4502,
Bethesda, MD 20892. 401–496–1852.
gnabel@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 11, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–656 Filed 1–23–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Allergy and
Infectious Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIAID; Vaccine Research Center,
Board of Scientific Counselors.
Date: January 30–31, 2006.
Time: January 30, 2006, 1 p.m. to 7 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Vaccine Research Center, 40 Convent Drive,
Bethesda, MD 20892.
Time: January 31, 2006, 9 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Vaccine Research Center, 40 Convent Drive,
Bethesda, MD 20892.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Units for HIV/AIDS Clinical
Trials Network (1)—FRA–05–002.
Date: February 14, 2006.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Mary J. Homer, PhD,
Scientific Review Administrator, Scientific
Review Program, National Institute of Allergy
and Infectious Diseases, DEA/NIH/DHHS,
6700–B Rockledge Drive MSC 7616 Room
3147, Bethesda, MD 20892. (301) 496–2550.
mjhomer@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\24JAN1.SGM
24JAN1
Federal Register / Vol. 71, No. 15 / Tuesday, January 24, 2006 / Notices
Dated: January 11, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–657 Filed 1–23–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
rmajette on PROD1PC67 with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 06–51, Review R01.
Date: February 15, 2006.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: H. George Hausch, PhD,
Acting Director, 45 Center Drive, Natcher
Building, Rm. 4AN44F, National Inst. of
Dental & Craniofacial Research, National
Institutes of Health, Bethesda, MD 20892.
(301) 594–2904. george_hausch@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 06–46, Review R21s, R03s.
Date: February 22, 2006.
Time: 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Raj K Krishnaraju, PhD,
MS, Scientific Review Administrator,
Scientific Review Branch, National Inst of
Dental & Craniofacial Research, National
Institutes of Health, 45 Center Dr. Room 4AN
32J, Bethesda, MD 20892. 301–594–4864.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 06–47, Review R21s.
Date: Feburary 24, 2006.
Time: 10:30 a.m. to 12:30 p.m.
VerDate Aug<31>2005
14:44 Jan 23, 2006
Jkt 208001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Raj K Krishnaraju, PhD,
MS, Scientific Review Administrator,
Scientific Review Branch, National Inst of
Dental & Craniofacial Research, National
Institutes of Health, 45 Center Dr. Rm 4AN
32J, Bethesda, MD 20892. 301–594–4864.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 06–52, Review R21s.
Date: Feburary 28, 2006.
Time: 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Raj K Krishnaraju, PhD,
MS, Scientific Review Administrator,
Scientific Review Branch, National Inst of
Dental & Craniofacial Research, National
Institutes of Health, 45 Center Dr. Rm 4AN
32J, Bethesda, MD 20892. 301–594–4864.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 11, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–661 Filed 1–23–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contact
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel;
Translational Research (BCI).
Date: February 14, 2006.
Time: 3 p.m. to 4 p.m.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
3867
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852.
(Telephone Conference Call).
Contact Person: Stanley C. Oaks, PhD,
Scientific Review Administrator, Division of
Extramural Activities, NIDCD, NIH,
Executive Plaza South, Room 400C, 6120
Executive Blvd-MSC 7180, Bethesda, MD
20892–7180. 301–496–8683. so14s@nih.gov.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel;
Translational Research (Laryngeal/Voice).
Date: February 14, 2006.
Time: 12:30 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852.
(Telephone Conference Call).
Contact Person: Stanley C. Oaks, PhD,
Scientific Review Administrator, Division of
Extramural Activities, NIDCD, NIH,
Executive Plaza South, Room 400C, 6120
Executive Blvd-MSC 7180, Bethesda, MD
20892–7180. 301–496–8683. so14s@nih.gov.
Name of Committee: Communication
Disorders Review Committee.
Date: February 15–16, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Washington, DC, 1400 M
Street, NW., Washington, DC 20005.
Contact Person: Melissa J. Stick, PhD,
MPH, Chief, Scientific Review Branch,
Scientific Review Branch, Division of
Extramural Research, NIDCD/NIH, 6120
Executive Blvd., Bethesda, MD 20892. 301–
496–8683.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel, Auditory
Neural Prostheses.
Date: February 21, 2006.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852.
(Telephone Conference Call).
Contact Person: Sheo Singh, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Activities, Executive Plaza South, Room
400C, 6120 Executive Blvd., Bethesda, MD
20892. 301–496–8683. singhs@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel; NIDCD
R03 Review Meeting.
Date: February 22–23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Shiguang Yang, PhD,
DVM, Scientific Review Administrator,
Division of Extramural Activities, NIDCD,
NIH, 6120 Executive Blvd., Bethesda, MD
20892. 301–496–8683.
Name of Committee: National Institute on
Deafness and Other Communications
E:\FR\FM\24JAN1.SGM
24JAN1
Agencies
[Federal Register Volume 71, Number 15 (Tuesday, January 24, 2006)]
[Notices]
[Pages 3866-3867]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-657]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Units for HIV/AIDS Clinical Trials
Network (1)--FRA-05-002.
Date: February 14, 2006.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Mary J. Homer, PhD, Scientific Review
Administrator, Scientific Review Program, National Institute of
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge
Drive MSC 7616 Room 3147, Bethesda, MD 20892. (301) 496-2550.
mjhomer@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
[[Page 3867]]
Dated: January 11, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-657 Filed 1-23-06; 8:45 am]
BILLING CODE 4140-01-M